Atlas Trials

A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-A1 in Healthy Young Adults

Clinical trial NCT07616934 · RECRUITING

Trial details

NCT number
NCT07616934
Sponsor
Vaxcyte, Inc.
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Group A Streptococcal Infection
Start date
2026-06-01
Primary completion
2027-12-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.